OncoCyte amended its loan and security agreement with Silicon Valley Bank pursuant to which Oncocyte obtained a new $3 million secured credit facility.
SVB Provides $10MM Revolver to Luna Innovations
October 15, 2019
Luna Innovations entered into a new $10 million revolving credit facility with Silicon Valley Bank.
Solar Capital, SVB Provide $10MM Term Loan for scPharmaceuticals
September 23, 2019
scPharmaceuticals completed a new $20 million term loan with Solar Capital and Silicon Valley Bank.
Oxford, SVB Expand Xeris Pharmaceuticals Facility to $85MM
September 11, 2019
Xeris Pharmaceuticals amended its loan and security agreement with Oxford Finance and Silicon Valley Bank, increasing the borrowing base from $45 million to up to $85 million.
SVB Closes $6.4MM Venture Debt Financing with Kantox
April 25, 2019
UK-based fintech company Kantox closed its second venture debt financing deal with Silicon Valley Bank.
SVB Appoints New Leaders in Funds Management & Commercial Banking
April 24, 2019
SVB Financial Group, the parent company of Silicon Valley Bank, has appointed John China president of SVB Capital and Dave Sabow head of Technology Banking.
Silicon Valley Bank Arranges $55MM Financing for US HealthVest
April 5, 2019
Silicon Valley Bank led a $55 million senior secured term loan for US HealthVest, a developer and operator of behavioral health facilities. The financing included a $30 million first lien revolving line and term loan from SVB and a $25 million second lien term loan from a third party.
SVB, MidCap Financial Provide $100MM Facility to Organogenesis
March 15, 2019
SVB and MidCap Financial entered a $100 million credit agreement with Organogenesis, a regenerative medicine company focused on product solutions for the advanced wound care and surgical and sports medicine markets.
